Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Pierdomenico

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
The Journal of Pharmacology and Experimental Therapeutics|May 24, 2008
P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in miceJere E Meredith, Lorin A Thompson, Jeremy H Toyn, et al.
Journal of Medicinal Chemistry|April 26, 2016
The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 KinasePamela A Haile, Bartholomew J Votta, Robert W Marquis, et al.
The Journal of Biological Chemistry|June 25, 2008
The amyloid-beta rise and gamma-secretase inhibitor potency depend on the level of substrate expressionCatherine R Burton, Jere E Meredith, Donna M Barten, et al.
International Journal of Alzheimer'S Disease|August 7, 2014
Identification and Preclinical Pharmacology of the γ-Secretase Modulator BMS-869780Jeremy H Toyn, Lorin A Thompson, Kimberley A Lentz, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
The Journal of Pharmacology and Experimental Therapeutics|May 24, 2008
P-glycoprotein efflux and other factors limit brain amyloid beta reduction by beta-site amyloid precursor protein-cleaving enzyme 1 inhibitors in miceJere E Meredith, Lorin A Thompson, Jeremy H Toyn, et al.
Journal of Medicinal Chemistry|April 26, 2016
The Identification and Pharmacological Characterization of 6-(tert-Butylsulfonyl)-N-(5-fluoro-1H-indazol-3-yl)quinolin-4-amine (GSK583), a Highly Potent and Selective Inhibitor of RIP2 KinasePamela A Haile, Bartholomew J Votta, Robert W Marquis, et al.
The Journal of Biological Chemistry|June 25, 2008
The amyloid-beta rise and gamma-secretase inhibitor potency depend on the level of substrate expressionCatherine R Burton, Jere E Meredith, Donna M Barten, et al.
International Journal of Alzheimer'S Disease|August 7, 2014
Identification and Preclinical Pharmacology of the γ-Secretase Modulator BMS-869780Jeremy H Toyn, Lorin A Thompson, Kimberley A Lentz, et al.
Pageof 4